These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22679696)

  • 1. [Selected prognostic factors of malignant uveal melanoma].
    Svetlosáková Z; Krásnik V; Gergisáková H; Babál P; Kusenda P
    Cesk Slov Oftalmol; 2012 Feb; 68(1):38-42. PubMed ID: 22679696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
    Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
    Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
    Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factors of extraocular spread after local treatment of uveal melanoma].
    Neroev VV; Saakian SV; Amirian AG; Val'skiĭ VV
    Vestn Oftalmol; 2011; 127(2):21-5. PubMed ID: 21721267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
    Coupland SE; Campbell I; Damato B
    Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveal melanoma.
    Kashyap S; Meel R; Singh L; Singh M
    Semin Diagn Pathol; 2016 May; 33(3):141-7. PubMed ID: 26972224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathways mediating liver metastasis in patients with uveal melanoma.
    Bakalian S; Marshall JC; Logan P; Faingold D; Maloney S; Di Cesare S; Martins C; Fernandes BF; Burnier MN
    Clin Cancer Res; 2008 Feb; 14(4):951-6. PubMed ID: 18281525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic melanoma in the eye and orbit.
    Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
    Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What else can we do for uveal melanoma].
    Li B; Xu XL
    Zhonghua Yan Ke Za Zhi; 2009 Apr; 45(4):289-92. PubMed ID: 19575957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
    Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
    Clin Cancer Res; 2006 Feb; 12(4):1383-91. PubMed ID: 16489097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
    Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
    Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uveal melanoma dormancy: an acceptable clinical endpoint?
    Blanco PL; Lim LA; Miyamoto C; Burnier MN
    Melanoma Res; 2012 Oct; 22(5):334-40. PubMed ID: 22895346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.
    Notting IC; Buijs JT; Que I; Mintardjo RE; van der Horst G; Karperien M; Missotten GS; Jager MJ; Schalij-Delfos NE; Keunen JE; van der Pluijm G
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1581-7. PubMed ID: 15851554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of nm23-H1 in uveal melanoma.
    Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
    Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optic nerve invasion of uveal melanoma: clinical characteristics and metastatic pattern.
    Lindegaard J; Isager P; Prause JU; Heegaard S
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3268-75. PubMed ID: 16877391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic uveal melanoma.
    Singh AD; Borden EC
    Ophthalmol Clin North Am; 2005 Mar; 18(1):143-50, ix. PubMed ID: 15763199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A survival analysis of patients with malignant uveal melanoma].
    Călugăru M; Mera M; Călugăru D
    Oftalmologia; 2000; 51(2):45-51. PubMed ID: 11021123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNS metastasis from malignant uveal melanoma: a clinical and histopathological characterisation.
    Holfort SK; Lindegaard J; Isager P; Prause JU; Heegaard S
    Br J Ophthalmol; 2009 May; 93(5):641-4. PubMed ID: 19091854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
    Shildkrot Y; Wilson MW
    Curr Opin Ophthalmol; 2009 Nov; 20(6):504-10. PubMed ID: 19644367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.